−3.220AUD
−5.57 MAUD
301.12 KAUD
10.84 M
About ZELIRA THERAPEUTICS LIMITED
Sector
CEO
Oludare Odumosu
Headquarters
Perth
Website
Founded
2003
ISIN
AU000000ZLD1
FIGI
BBG000K4GYF0
Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The firm engages in the research and development of cannabinoid-based formulations for the treatment of a variety of medical conditions. It focuses on human clinical trial program and pre-clinical research program. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ZLD is 0.710 AUD — it has decreased by 1.39% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ZELIRA THERAPEUTICS LIMITED stocks are traded under the ticker ZLD.
ZLD stock is 1.41% volatile and has beta coefficient of −0.05. Check out the list of the most volatile stocks — is ZELIRA THERAPEUTICS LIMITED there?
Yes, you can track ZELIRA THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
ZLD stock has risen by 2.90% compared to the previous week, the month change is a 2.90% rise, over the last year ZELIRA THERAPEUTICS LIMITED has showed a 26.80% decrease.
ZLD net income for the last quarter is −34.13 M AUD, while the quarter before that showed −2.30 M AUD of net income which accounts for −1.39 K% change. Track more ZELIRA THERAPEUTICS LIMITED financial stats to get the full picture.
Today ZELIRA THERAPEUTICS LIMITED has the market capitalization of 8.17 M, it has increased by 1.46% over the last week.
No, ZLD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ZLD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZELIRA THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZELIRA THERAPEUTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZELIRA THERAPEUTICS LIMITED stock shows the sell signal. See more of ZELIRA THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZELIRA THERAPEUTICS LIMITED EBITDA is −6.70 M AUD, and current EBITDA margin is −2.28 K%. See more stats in ZELIRA THERAPEUTICS LIMITED financial statements.